$49.43
0.310.63%
At close: Sep 2, 5:00 PM EST
$49.43
N/A
After Hours: 4:00 PM EST
Conmed Corp
CNMDNYSE
Dividend: The dividend Ex-Date is in 13 days
Conmed Earnings & Forecasts
Conmed (CNMD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Conmed Guidance
Conmed (CNMD) last issued guidance on July 29, 2026 for fiscal year 2026. The company guided earnings per share in the range of $4.48 - $4.6, compared to a consensus EPS estimate of $4.37. Conmed also guided revenue in the range of $1.36B - $1.37B for the period.
Compared to prior guidance, Conmed maintained its revenue forecast from a prior range of $1.35B - $1.38B.
Conmed has issued 24 guidance updates between October 26, 2022 and July 29, 2026. During this period, the company raised its outlook 7 times and lowered it 7 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.11 | $0.82 | $1.32 | $1.05 |
| Actual | $1.38 | $0.89 | $1.43 | $1.08 |
| Surprise | +24.3% | +8.54% | +8.33% | +2.86% |
| Revenue | ||||
| Estimate | $337.4M | $310.6M | $366.6M | $335.5M |
| Actual | $343.5M | $317.0M | $373.2M | $337.9M |
| Surprise | +1.80% | +2.07% | +1.80% | +0.73% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.00 | $1.27 | $0.88 | $1.16 |
| Revenue | ||||
| Consensus | $336.4M | $369.1M | — | — |
